Home » Topics » BioWorld Science

BioWorld Science
RSS

Lilly discloses new serotonergic agents

Sep. 6, 1996

NS-2710 in development for anxiety

Sep. 6, 1996

Melatonergic agents from ADIR

Sep. 6, 1996

MRI contrast agent from Advanced Magnetics cleared for launch

Sep. 6, 1996

Agreement reached on tests for hepatitis C virus

Sep. 6, 1996

Assays for the diagnosis of Alzheimer's disease

Sep. 6, 1996

Retinoid compound from Sparta enters U.S. clinical trials

Sep. 6, 1996

Oral treatment for periodontitis filed for approval

Sep. 6, 1996

A new CETP inhibitor from Schering-Plough

Sep. 6, 1996

Japanese researchers describe natural lipid-lowering agents

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...